A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors

Clinical trial NCT06976437 · RECRUITING

Trial details

NCT number: NCT06976437
Sponsor: YANRU WANG
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

B Cell Lymphoma Multiple Myeloma

Start date: 2025-05-06
Primary completion: 2027-05-20
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.